Noble Capital Markets Initiates Equity Research Coverage on Xcel Brands (XELB)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on Xcel Brands today with his report titled “Likely To Be The Trough Toward Improved Results"
Noble Capital Markets Initiates Equity Research Coverage on Eledon Pharmaceuticals (ELDN)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Eledon Pharmaceuticals today with his report titled "Initiating Coverage With An Outperform Rating and $10 Price Target"
Noble Capital Markets Initiates Equity Research Coverage on QuantaSing Group Limited (QSG)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on QuantaSing Group today with his report titled "A Favorable Course For Revenue and Cash Flow Growth"
Noble Capital Markets Initiates Equity Research Coverage on Bitcoin Depot (BTM)
Noble’s Equity Research Analyst Joe Gomes launched coverage on Bitcoin Depot today with his report titled "Initiating Coverage: Bringing Bitcoin To A "Store" Near You"
Noble Capital Markets Initiates Equity Research Coverage on The ODP Corporation (ODP)
Noble’s Equity Research Analyst Joe Gomes launched coverage on The ONE Group Hospitality today with his report titled “Initiation: Not Your Father's Office Depot"
Noble Capital Markets Initiates Equity Research Coverage on AZZ Inc. (AZZ)
Noble’s Equity Research AnalystMichael Heim launched coverage on AZZ Inc. today with his report titled "Initiating Coverage With an Outperform Rating and $60 Price Target"
Noble Capital Markets Initiates Equity Research Coverage on Bit Digital (BTBT)
Noble’s Equity Research Analyst Joe Gomes launched coverage on Bit Digital today with his report titled "Into the Digital Mines"
Noble Capital Markets Initiates Equity Research Coverage on Saga Communications, Inc. (SGA)
Noble’s Equity Research Analyst Michael Kupinski launched coverage on Saga Communications today with his report titled "Starts A New Chapter"
Noble Capital Markets Initiates Equity Research Coverage on GeoVax Labs Inc. (GOVX)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on GeoVax Labs, Inc. today with his report titled "Initiating Coverage With $6 Price Target"